A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

SIMPLE SUMMARY: Left ventricular dysfunction (LVD) induced by anthracycline-based cancer chemotherapy (ACC) is becoming an urgent healthcare concern. Myocardial fibrosis (MF) may contribute to LVD after ACC. We show that elevated circulating levels of procollagen type I C-terminal propeptide (PICP,...

Descripción completa

Detalles Bibliográficos
Autores principales: de la Fuente, Ana, Santisteban, Marta, Lupón, Josep, Aramendía, José Manuel, Díaz, Agnes, Santaballa, Ana, Hernándiz, Amparo, Sepúlveda, Pilar, Cediel, Germán, López, Begoña, Picazo, José María López, Mazo, Manuel M., Rábago, Gregorio, Gavira, Juan José, García-Bolao, Ignacio, Díez, Javier, González, Arantxa, Bayés-Genís, Antoni, Ravassa, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221256/
https://www.ncbi.nlm.nih.gov/pubmed/35740602
http://dx.doi.org/10.3390/cancers14122941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221256/
https://www.ncbi.nlm.nih.gov/pubmed/35740602
http://dx.doi.org/10.3390/cancers14122941

Ejemplares similares